newscontact us

ThermoGenesis Announces Registration Approval of AXP in China

RANCHO CORDOVA, Calif., May 8, 2013 (GLOBE NEWSWIRE) — ThermoGenesis Corp. (Nasdaq:KOOL), a leading supplier of enabling technologies for the processing and storage of stem cells and other biological tissues, today said it has received registration approval for its AXP® AutoXpress® (AXP) product from China’s State Food & Drug Administration (SFDA). The product is used to concentrate stem cells from cord blood and, with this approval, the Company will immediately initiate commercial distribution of the product in China, one of the world’s fastest growing cord blood markets.